From The Desk Of
CW Insider, May 18
1:58 PM MDT | May 15, 2009 | Robert Westervelt
Dow Chemical chairman and CEO Andrew Liveris defended the company’s acquisition of Rohm and Haas at Dow’s annual meeting last week, noting that allowing a competitor to acquire the company would have had a “profound and negative effect” on Dow. In Geneva, chemical makers faced criticism that industry is failing to provide sufficient funding for Strategic Approach of International Chemicals Management at the United Nations (UN) International Conference on Chemicals Management. Other articles of interest can be found at...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee